NCT02744287 2026-02-23Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid TumorsRegeneron PharmaceuticalsPhase 1 Terminated52 enrolled
NCT00868595 2019-10-08MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate CancerBellicum PharmaceuticalsPhase 1 Completed18 enrolled